Semaglutide (Ozempic) is 1 of 15 medications that will be included in yearly price negotiations between Medicare and ...

After waking up from the procedure, he told me he could take full breaths for the first time in years,” Dr. Mark Sigler said ...

Medicare has chosen 15 prescription medications for price negotiations this year, building off a first round of negotiations ...

If successful, the result could be lower Medicare Part D prices for drugs used to create a variety of conditions, such as ...

The suit comes exactly one year after 22-year-old Cole Schmidtknecht died from cardiac arrest after suffering a severe asthma attack.

BLVR is designed for patients with severe or very severe COPD who continue to experience significant shortness of breath despite other medical therapy, including inhalers, medications, and ...

From being able to address patient questions to how this could impact your local pharmacy, there are still a lot of moving parts.

MRI of inhaled perfluoropropane can assess regional lung ventilation and monitor improvements in response to medication ...

Novo Nordisk's Ozempic and Wegovy are among 15 drugs targeted for Medicare price negotiations in 2027. The U.S. aims to cut ...

In the USA, 14.8 million people were diagnosed with chronic obstructive pulmonary disease (COPD) in 2010 and nearly as many are expected to go undiagnosed. Indirect costs of COPD were projected to ...

UK pharma major AstraZeneca’s Fasenra (benralizumab), with its highly anticipated Phase III data to be showcased at the 2025 ...